Search

everythinglearnresearchcommunity

for

Search:↓

The study aims to find the most effective treatments for male pattern baldness.

The conclusion is that the risk of losing significance in meta-analysis results increases with smaller effects and more missing data, and using the median standard deviation for imputation is recommended.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Adding aesthetic therapies to medications doesn't improve male pattern baldness treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Combining PRP with Minoxidil improves hair density and thickness more than Minoxidil alone.

Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.

Single-spin and double-spin PRP methods are equally effective for treating hair loss.

Cosmetic procedures can cause serious eye problems, so awareness and safety are crucial.

Vertex pattern hair loss linked to higher prostate cancer risk.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Most Cochrane Skin Group reviews are helpful for improving dermatology practices, but some lack enough evidence for clinical recommendations.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Physical activity, height, and smoking affect prostate cancer risk.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.